Frontlight ResearchEarly access
Head and neck cancer trials in China
216 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Not yet taking people in ChinaA Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
- Where
- Shanghai
- Age
- 18 years and over
- People
- 66
- Run by
- Shanghai Bao Pharmaceuticals Co., Ltd.
See details and how to joinNCT07036185 - No phaseTaking peopleNoninvasive Intratumor Heterogeneity Evaluation in HNSCC
- Where
- Chongqing
- Age
- 15 years to 89 years
- People
- 700
- Run by
- First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT07027280 - Phase 2Taking peopleAK104 and Low-dose Radiation in Recurrent/Metastatic HNSCC After Failure of First-line Systemic Therapy
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 52
- Run by
- Fudan University
See details and how to joinNCT06494995 - Phase 1/2Taking peopleAK129 Combination Therapy for Advanced Solid Tumors
- Where
- Shenyang
- Age
- 18 years to 75 years
- People
- 230
- Run by
- Akeso
See details and how to joinNCT06943820 - Phase 2Taking peopleCetuximab + Tislelizumab + Chemotherapy in the Treatment of Unresectable LA HNSCC
- Where
- Chongqing
- Age
- 18 years and over
- People
- 42
- Run by
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT06978829 - Phase 3Not yet taking people in ChinaComparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 168
- Run by
- Fudan University
See details and how to joinNCT06957938 - Phase 1/2Taking peopleHydroxychloroquine Sulfate Tablets for Radiation-induced Oral Mucositis
- Where
- Chengdu
- Age
- 18 years to 80 years
- People
- 158
- Run by
- Xingchen Peng
See details and how to joinNCT06939582 - Phase 2Not yet taking people in ChinaChemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer
- Where
- Guangzhou
- Age
- 18 years to 65 years
- People
- 50
- Run by
- Sun Yat-sen University
See details and how to joinNCT06861712 - Phase 1/2Enrolling by invitationEvaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors
- Where
- Jinan
- Age
- 18 years and over
- People
- 100
- Run by
- Man Hu
See details and how to joinNCT06690216 - Phase 2Not yet taking people in ChinaThe Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCC
- Where
- Hanzhou
- Age
- 18 years to 70 years
- People
- 30
- Run by
- Sir Run Run Shaw Hospital
See details and how to joinNCT06895369 - Phase 2Taking peopleSurufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCC
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 24
- Run by
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT06876844 - Phase 1/2Taking peopleInduction IBI110 and Sintilimab with Chemotherapy in LA HNSCC
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 27
- Run by
- Fudan University
See details and how to joinNCT06494943 - No phaseNot yet taking people in ChinaThe Relationship Between The Differential Expression Of FosB Protein In Laryngeal Cancer Tissues And Clinical Prognosis
- Where
- Nanchong
- Age
- 35 years to 90 years
- People
- 100
- Run by
- Yang ji
See details and how to joinNCT06836765 - Phase 2Taking peopleTirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable Oral Squamous Cell Carcinoma
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 116
- Run by
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT06470217 - Phase 2Not yet taking people in ChinaPhase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Shanghai
- Age
- 18 years and over
- People
- 80
- Run by
- Fudan University
See details and how to joinNCT06814067 - No phaseNot yet taking people in ChinaReconstruction of Cervical Lymphatic System During Head and Neck Squamous Cell Carcinoma Surgery
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 23
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06815705 - Phase 2Taking peopleStudy of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China
- Where
- Beijing
- Age
- 18 years and over
- People
- 150
- Run by
- Yuankai Shi
See details and how to joinNCT04857164 - Phase 3Not yet taking people in ChinaNano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck Squamous Cell Carcinoma After Surgery.
- Where
- Chengdu
- Age
- 18 years to 85 years
- People
- 96
- Run by
- Changchun GeneScience Pharmaceutical Co., Ltd.
See details and how to joinNCT06772428 - No phaseEnrolling by invitationHypofractionated Radiotherapy for HNSCC in Elderly Patients
- Where
- Beijing
- Age
- 65 years and over
- People
- 51
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06768125 - Phase 2Taking peopleBone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC
- Where
- Changsha
- Age
- 18 years to 70 years
- People
- 30
- Run by
- Hunan Cancer Hospital
See details and how to joinNCT06752798 - Phase 2Not yet taking people in ChinaPreoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 28
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT06728618 - Phase 2Taking peopleIntra-arterial Chemotherapy Combined with Radiotherapy and Immunotherapy for HNSCC
- Where
- Beijing
- Age
- 18 years and over
- People
- 50
- Run by
- Beijing Tongren Hospital
See details and how to joinNCT06725498 - No phaseTaking peopleThe Value of CEUS in Assessing the Response of Cervical Lymph Nodes After NACI for HNSCC
- Where
- Guangzhou
- People
- 100
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06727162 - No phaseNot yet taking people in ChinaEfficacy and Safety of a Third-Course of Neoadjuvant Immunochemotherapy Combined With SBRT in Locally Advanced Head and Neck Squamous Cell Carcinoma Patients With Stable Disease After Two Treatment Courses: A Single-Arm Exploratory Study
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 20
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06722495 - Phase 2Taking peopleA Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 90
- Run by
- Lei Liu
See details and how to joinNCT06444009